Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GABRA1 | P14867 | 4/20 | 0.46 |
| ▸ | GABRB2 | P47870 | 4/20 | 0.46 |
| ▸ | TAAR1 | Q96RJ0 | 2/20 | 0.43 |
| ▸ | HTR1A | P08908 | 1/20 | 0.43 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.36 |
| ▸ | SCN5A | Q14524 | 2/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.35 |
| ▸ | MGLL | Q99685 | 1/20 | 0.33 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.33 |
| ▸ | NLRP3 | Q96P20 | 1/20 | 0.33 |
| ▸ | DHFR | P00374 | 1/20 | 0.32 |
| ▸ | DAO | P14920 | 1/20 | 0.32 |
| ▸ | CACNA1C | Q13936 | 1/20 | 0.32 |
| ▸ | ELANE | P08246 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28734581 | 0.85 | GABRA1 (0.37) | GABRA1GABRB2TAAR1HTR1ADAO | |
| SCHEMBL245773 | 0.82 | GABRA1 (0.57) | GABRA1GABRB2TAAR1HTR1AKCNH2 | |
| Methylamine SCHEMBL27545014 | 0.79 | GABRA1 (0.55) | GABRA1GABRB2TAAR1HTR1AKCNH2 | |
| Methane SCHEMBL28776675 | 0.79 | GABRA1 (0.55) | GABRA1GABRB2TAAR1HTR1AKCNH2 | |
| SCHEMBL31498538 | 0.79 | GABRA1 (0.55) | GABRA1GABRB2TAAR1HTR1AKCNH2 | |
| SCHEMBL88662 | 0.79 | — | — | |
| Ammonia Solution, Strong SCHEMBL27320869 | 0.79 | GABRA1 (0.55) | GABRA1GABRB2TAAR1HTR1AKCNH2 | |
| SCHEMBL307046 | 0.78 | GABRA1 (0.48) | GABRA1GABRB2TAAR1HTR1AKCNH2 | |
| SCHEMBL3316034 | 0.78 | GABRA1 (0.32) | GABRA1GABRB2 | |
| SCHEMBL9000240 | 0.77 | GABRA1 (0.52) | GABRA1GABRB2TAAR1HTR1AKCNH2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 84 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113683716-A | Ethylene polymerization catalyst, preparation method thereof and preparation method of ethylene-isobutylene copolymer | 中国石油天然气股份有限公司 | 2021-11-23 | — | — | CN | claimed |
| US-20120178617-A1 | Preparation of Supported Silyl-Capped Silica-Bound Anion Activators and Associated Catalysts | EXXONMOBIL CHEMICAL PATENTS INC. | 2012-07-12 | — | — | US | claimed |
| US-8163854-B2 | Preparation of supported silyl-capped silica-bound anion activators and associated catalysts | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2012-04-24 | — | — | US | claimed |
| US-20110015357-A1 | Preparation of Supported Silyl-Capped Silica-Bound Anion Activators and Associated Catalysts | EXXONMOBIL CHEMICAL PATENTS INC. | 2011-01-20 | — | — | US | claimed |
| US-7847038-B2 | Preparation of supported silyl-capped silica-bound anion activators and associated catalysts | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2010-12-07 | — | — | US | claimed |
| US-20070161803-A1 | Method of asymmetrically reducing 4-[5-(imidazol-1-yl)-2-methylbenzoyl]-3,5- dimethylbenzoic acid or ester thereof | MITSUBISHI PHARMA CORPORATION (JP) | 2007-07-12 | — | — | US | claimed |
| EP-1719764-A1 | METHOD OF ASYMMETRICALLY REDUCING 4- 5-(IMIDAZOL-1-YL)-2-MET HYLBENZOYL -3,5-DIMETHYL-BENZOIC ACID OR ESTER THEREOF | Mitsubishi Pharma Corporation (JP) | 2006-11-08 | — | — | EP | claimed |
| EP-4703367-A1 | RUTHENIUM COMPLEX, METHOD FOR PRODUCING SILYL GROUP-CONTAINING COMPOUND, SILYL GROUP-CONTAINING POLYMER MIXTURE, CURABLE COMPOSITION, AND CURED PRODUCT | Kaneka Corporation (JP) | 2026-03-04 | — | — | EP | disclosed |
| EP-4703406-A1 | HYDROLYZABLE SILYL GROUP-CONTAINING POLYOXYALKYLENE POLYMER, CURABLE COMPOSITION, AND CURED PRODUCT | Kaneka Corporation (JP) | 2026-03-04 | — | — | EP | disclosed |
| US-20260049182-A1 | RUTHENIUM COMPLEX, METHOD FOR PRODUCING SILYL GROUP-CONTAINING COMPOUND, SILYL GROUP-CONTAINING POLYMER MIXTURE, CURABLE COMPOSITION, AND CURED PRODUCT | KANEKA CORPORATION (JP) | 2026-02-19 | — | — | US | disclosed |
| US-20260049176-A1 | HYDROLYZABLE SILYL GROUP-CONTAINING POLYOXYALKYLENE POLYMER, CURABLE COMPOSITION, AND CURED PRODUCT | KANEKA CORPORATION (JP) | 2026-02-19 | — | — | US | disclosed |
| US-20250137196-A1 | HYDROPHOBIC COATING AND METHOD OF APPLICATION TO SUBSTRATES | GREEN THEME TECHNOLOGIES, INC. | 2025-05-01 | — | — | US | disclosed |
| WO-2025090528-A1 | HYDROPHOBIC COATING AND METHOD OF APPLICATION TO SUBSTRATES | GREEN THEME TECHNOLOGIES, INC. (US) | 2025-05-01 | — | — | WO | disclosed |
| US-20090018290-A1 | Preparation of Supported Silyl-Capped Silica-Bound Anion Activators and Associated Catalysts | EXXONMOBIL CHEMICAL PATENTS INC. | 2009-01-15 | — | — | US | disclosed |
| US-20070161803-A1 | Method of asymmetrically reducing 4-[5-(imidazol-1-yl)-2-methylbenzoyl]-3,5- dimethylbenzoic acid or ester thereof | MITSUBISHI PHARMA CORPORATION (JP) | 2007-07-12 | — | — | US | disclosed |
| EP-1719764-A1 | METHOD OF ASYMMETRICALLY REDUCING 4- 5-(IMIDAZOL-1-YL)-2-MET HYLBENZOYL -3,5-DIMETHYL-BENZOIC ACID OR ESTER THEREOF | Mitsubishi Pharma Corporation (JP) | 2006-11-08 | — | — | EP | disclosed |
| EP-0191260-B1 | PENTACOORDINATED SILICON COMPLEXES, PROCESS FOR THEIR PREPARATION AND THEIR USE IN PREPARING ORGANOSILANES | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (FR) | 1989-05-31 | — | — | EP | disclosed |
| US-4617413-A | Pentacoordinate silicon complexes, the process for their preparation and their application to the preparation of organosilanes | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 1986-10-14 | — | — | US | disclosed |
| EP-0191260-A1 | Pentacoordinated silicon complexes, process for their preparation and their use in preparing organosilanes | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (FR) | 1986-08-20 | — | — | EP | disclosed |
| US-4474976-A | ARYLATION | GENERAL ELECTRIC COMPANY (US) | 1984-10-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260049176-A1 | HYDROLYZABLE SILYL GROUP-CONTAINING POLYOXYALKYLENE POLYMER, CURABLE COMPOSITION, AND CURED PRODUCT | PSMA1, LIPA, SGMS1 | GABRA1 3348/4885GABRB2 4317/4885TAAR1 2034/4885 |
| US-20260049182-A1 | RUTHENIUM COMPLEX, METHOD FOR PRODUCING SILYL GROUP-CONTAINING COMPOUND, SILYL GROUP-CONTAINING POLYMER MIXTURE, CURABLE COMPOSITION, AND CURED PRODUCT | ILK, CROCC, SEM1 | GABRA1 3297/4885GABRB2 3399/4885TAAR1 2876/4885 |
| US-20090018290-A1 | Preparation of Supported Silyl-Capped Silica-Bound Anion Activators and Associated Catalysts | TLL2, ESPL1, CCNL2 | GABRA1 3885/4885GABRB2 4000/4885TAAR1 2393/4885 |
| US-20070161803-A1 | Method of asymmetrically reducing 4-[5-(imidazol-1-yl)-2-methylbenzoyl]-3,5- dimethylbenzoic acid or ester thereof | DDC, AADAC, ALG3 | GABRA1 709/4885GABRB2 853/4885TAAR1 3291/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.